Back to search results

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

Abroad (travel likely)RecruitingPHASE3

Conditions

Asthma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Novartis Investigative Site, CABA, Buenos Aires, Argentina

  • Novartis Investigative Site, CABA, Buenos Aires, Argentina

  • Novartis Investigative Site, CABA, Buenos Aires, Argentina

  • Novartis Investigative Site, Mendoza, Mendoza Province, Argentina

  • Novartis Investigative Site, Rosario, Santa Fe Province, Argentina

  • Novartis Investigative Site, Rosario, Santa Fe Province, Argentina

  • Novartis Investigative Site, Graz, Austria

  • Novartis Investigative Site, Salzburg, Austria

  • Novartis Investigative Site, Sankt Pölten, Austria

  • Novartis Investigative Site, Sorocaba, São Paulo, Brazil

  • Novartis Investigative Site, Rousse, Bulgaria

  • Novartis Investigative Site, Sevlievo, Bulgaria

  • Novartis Investigative Site, Bucaramanga, Santander Department, Colombia

  • Novartis Investigative Site, Ibague, Tolima Department, Colombia

  • Novartis Investigative Site, Cali, Valle del Cauca Department, Colombia

  • Novartis Investigative Site, Plzen Bory, Czechia

  • Novartis Investigative Site, Prague, Czechia

  • Novartis Investigative Site, Athens, Greece

  • Novartis Investigative Site, Chaïdári, Greece

  • Novartis Investigative Site, Heraklion Crete., Greece

  • Novartis Investigative Site, Pátrai, Greece

  • Novartis Investigative Site, Thessaloniki, Greece

  • Novartis Investigative Site, Guatemala City, GTM, Guatemala

  • Novartis Investigative Site, Guatemala City, Guatemala

  • Novartis Investigative Site, Budapest, Hungary

  • Novartis Investigative Site, Gödöllő, Hungary

  • Novartis Investigative Site, Szeged, Hungary

  • Novartis Investigative Site, Szigetvár, Hungary

  • Novartis Investigative Site, Brescia, BS, Italy

  • Novartis Investigative Site, Catania, CT, Italy

  • Novartis Investigative Site, Florence, FI, Italy

  • Novartis Investigative Site, Pavia, PV, Italy

  • Novartis Investigative Site, Roma, RM, Italy

  • Novartis Investigative Site, Naples, Italy

  • Novartis Investigative Site, Guadalajara, Jalisco, Mexico

  • Novartis Investigative Site, Guadalajara, Jalisco, Mexico

  • Novartis Investigative Site, San Juan del Río, Querétaro, Mexico

  • Novartis Investigative Site, Villahermosa, Tabasco, Mexico

  • Novartis Investigative Site, Querétaro, Mexico

  • Novartis Investigative Site, Panama City, Provincia de Panamá, Panama

  • Novartis Investigative Site, Lisbon, Portugal

  • Novartis Investigative Site, Lisbon, Portugal

  • Novartis Investigative Site, Porto, Portugal

  • Novartis Investigative Site, Porto, Portugal

  • Novartis Investigative Site, Timișoara, Timiș County, Romania

  • Novartis Investigative Site, Bucharest, Romania

  • Novartis Investigative Site, Bloemfontein, Free State, South Africa

  • Novartis Investigative Site, Pretoria, Gauteng, South Africa

  • Novartis Investigative Site, Raslouw Centurion, Gauteng, South Africa

  • Novartis Investigative Site, Cape Town, Western Cape, South Africa

  • Novartis Investigative Site, George, Western Cape, South Africa

  • Novartis Investigative Site, Cape Town, Western Province, South Africa

  • Novartis Investigative Site, Cape Town, South Africa

  • Novartis Investigative Site, Centurion, South Africa

  • Novartis Investigative Site, Esplugues, Barcelona, Spain

  • Novartis Investigative Site, Sabadell, Barcelona, Spain

  • Novartis Investigative Site, Barcelona, Spain

  • Novartis Investigative Site, Córdoba, Spain

  • Novartis Investigative Site, Madrid, Spain

  • Novartis Investigative Site, Málaga, Spain

  • Novartis Investigative Site, Haiphong, Vietnam

  • Novartis Investigative Site, Hanoi, Vietnam

  • Novartis Investigative Site, Ho Chi Minh City, Vietnam

Study leads

  • Novartis Pharmaceuticals

    Study Director

    Novartis Pharmaceuticals

View source on ClinicalTrials.gov(opens in a new tab)